Biovotec AS completes planned placement of NOK 5 Million
May 15, 2017
Biovotec has as communicated in the General Assembly on the 26th of February 2017 used it´s mandate to raise MNOK 5,0 . The funds will support the ongoing operations and trials, and will give Biovotec the freedom to build momentum going forward. The share price was NOK 157, which is the same share price used in the three previous rounds.
“ It was reassuring to see the commitment of the existing shareholders and related parties to support the development of Biovotec! This limited capital increase together with our existing funds will enable us to achieve several critical milestones being the basis for the further development of the company “ : head of board Mårten Wigstøl
I'm busy working on my blog posts. Watch this space!